Skip to main content
Premium Trial:

Request an Annual Quote

Waters Says Q1 Sales Rise 8.2 Percent as R&D and Per-Share Profits Grow

NEW YORK, April 26 (GenomeWeb News) - Waters today reported that first-quarter sales rose 8.2 percent atop increasing R&D spending and a narrowed profit.

 

Total sales for the three months ended April 1 increased to $290.2 million from $268.3 million in the year-ago period.

 

R&D spending jumped to $19 million from $16.7 million year over year.

 

Profits for the quarter declined to $44.2 million from $46.6 million year over year though per-share income grew to $.42 from $.39.

 

Waters said it had around $481.2 million in cash and equivalents as of April 1.

 

"A favorable convergence of market factors including rapid uptake of our proprietary ACQUITY UPLC chromatography technology, robust business growth in India and China and the continued strength of our global industrial accounts, enabled us to perform at a level above our projections and provides a higher level of confidence for the year," Douglas Berthiaume, chairman, president, and CEO, said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.